These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36746325)

  • 21. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids.
    Winhusen T; Wilder C; Lyons MS; Theobald J; Kropp F; Lewis D
    Drug Alcohol Depend; 2020 Nov; 216():108265. PubMed ID: 32919098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist program.
    Jacka BP; Ziobrowski HN; Lawrence A; Baird J; Wentz AE; Marshall BDL; Wightman RS; Mello MJ; Beaudoin FL; Samuels EA
    Acad Emerg Med; 2022 Mar; 29(3):294-307. PubMed ID: 34738277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Randomized Controlled Trial of a Citywide Emergency Department Care Coordination Program to Reduce Prescription Opioid Related Emergency Department Visits.
    Neven D; Paulozzi L; Howell D; McPherson S; Murphy SM; Grohs B; Marsh L; Lederhos C; Roll J
    J Emerg Med; 2016 Nov; 51(5):498-507. PubMed ID: 27624507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HEALing (Helping to End Addiction Long-term
    HEALing Communities Study Consortium
    Drug Alcohol Depend; 2020 Dec; 217():108335. PubMed ID: 33248391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting Mortality Risk After a Hospital or Emergency Department Visit for Nonfatal Opioid Overdose.
    Guo J; Lo-Ciganic WH; Yang Q; Huang JL; Weiss JC; Cochran G; Malone DC; Kuza CC; Gordon AJ; Donohue JM; Gellad WF
    J Gen Intern Med; 2021 Apr; 36(4):908-915. PubMed ID: 33481168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose.
    Bohnert AS; Bonar EE; Cunningham R; Greenwald MK; Thomas L; Chermack S; Blow FC; Walton M
    Drug Alcohol Depend; 2016 Jun; 163():40-7. PubMed ID: 27062245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing scalable, technology-supported behavioral interventions to prevent opioid misuse among adolescents and young adults in the emergency department: A randomized controlled trial protocol.
    Bonar EE; Kidwell KM; Bohnert ASB; Bourque CA; Carter PM; Clark SJ; Glantz MD; King CA; Losman ED; McCabe SE; Philyaw-Kotov ML; Prosser LA; Voepel-Lewis T; Zheng K; Walton MA
    Contemp Clin Trials; 2021 Sep; 108():106523. PubMed ID: 34352386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing the Opioid Rapid Response System™ for Lay Citizen Response to the Opioid Overdose Crisis: a Randomized Controlled Trial.
    Hecht ML; Jayawardene W; Henderson C; Pezalla A; Flood-Grady E; Krieger JL; Frederick A; Parker M; Ables E
    Prev Sci; 2023 Oct; 24(7):1386-1397. PubMed ID: 37737966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. User-centred clinical decision support to implement emergency department-initiated buprenorphine for opioid use disorder: protocol for the pragmatic group randomised EMBED trial.
    Melnick ER; Jeffery MM; Dziura JD; Mao JA; Hess EP; Platts-Mills TF; Solad Y; Paek H; Martel S; Patel MD; Bankowski L; Lu C; Brandt C; D'Onofrio G
    BMJ Open; 2019 May; 9(5):e028488. PubMed ID: 31152039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.
    Watson DP; Swartz JA; Robison-Taylor L; Mackesy-Amiti ME; Erwin K; Gastala N; Jimenez AD; Staton MD; Messmer S
    BMC Public Health; 2021 Mar; 21(1):630. PubMed ID: 33789642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A qualitative study of emergency department patients who survived an opioid overdose: Perspectives on treatment and unmet needs.
    Hawk K; Grau LE; Fiellin DA; Chawarski M; O'Connor PG; Cirillo N; Breen C; D'Onofrio G
    Acad Emerg Med; 2021 May; 28(5):542-552. PubMed ID: 33346926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.
    Parkin S; Neale J; Brown C; Jones JD; Brandt L; Castillo F; Campbell ANC; Strang J; Comer SD
    Int J Drug Policy; 2021 Jan; 87():102968. PubMed ID: 33096365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study of a mixed-method approach to design an ED-based peer mHealth referral tool for HIV/HCV and opioid overdose prevention services.
    Knaub RJ; Evans J; Yang C; Roura R; McGinn T; Verschoore B; Ricketts EP; Rothman RE; Latkin CA; Hsieh YH
    Drug Alcohol Depend; 2022 Sep; 238():109585. PubMed ID: 35926299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?
    Medicaid Outcomes Distributed Research Network
    J Subst Abuse Treat; 2022 Nov; 142():108807. PubMed ID: 35649885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.
    Klemperer EM; Wreschnig L; Crocker A; King-Mohr J; Ramniceanu A; Brooklyn JR; Peck KR; Rawson RA; Evans EA
    J Subst Use Addict Treat; 2023 Sep; 152():209103. PubMed ID: 37311520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A medical student-led model for telephone-based opioid overdose education and naloxone distribution during the COVID-19 pandemic.
    Hughes TM; Kalicki A; Huxley-Reicher Z; Toribio W; Samuels DL; Weiss JJ; Herscher M; Wang L
    Subst Abus; 2022; 43(1):988-992. PubMed ID: 35435812
    [No Abstract]   [Full Text] [Related]  

  • 39. Retrospective analysis of patterns of opioid overdose and interventions delivered at a tertiary hospital emergency department: impact of COVID-19.
    Potaka KL; Freeman R; Soo D; Nguyen NA; Sim TF; Moullin JC
    BMC Emerg Med; 2022 Apr; 22(1):62. PubMed ID: 35397487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial.
    Whiteside LK; Huynh L; Morse S; Hall J; Meurer W; Banta-Green CJ; Scheuer H; Cunningham R; McGovern M; Zatzick DF
    J Subst Abuse Treat; 2022 May; 136():108666. PubMed ID: 34952745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.